HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Changmei Cheng Selected Research

CCTA-1523

7/2017Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Changmei Cheng Research Topics

Disease

4Neoplasms (Cancer)
07/2017 - 09/2010
1Infarction (Infarctions)
05/2010
1Reperfusion Injury
05/2010
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2010
1Brain Ischemia (Cerebral Ischemia)
05/2010

Drug/Important Bio-Agent (IBA)

2Dichloroacetic AcidIBA
12/2012 - 09/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2017
1CCTA-1523IBA
07/2017
1Adenosine Triphosphate (ATP)IBA
01/2017
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2017
1scutellarinIBA
05/2010
1ProdrugsIBA
05/2010

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2017